Evaluation of Pathwork Tissue of Origin (TOO) Test for Human Malignancies
NCT00977639 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2
Last updated 2010-03-29
Summary
The pathworks tissue of origin test is a microarray-based test with the goal of identifying the tissue of origin in patients with metastatic tumors of unknown primary site.
Conditions
- Neoplasm Metastasis
Interventions
- PROCEDURE
-
Pathwork TOO test
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
James L Zehnder · Stanford University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-02-29
- Primary Completion
- 2009-06-30
- Completion
- 2009-06-30
Countries
- United States
Study Locations
More Related Trials
-
TRU-Cut Biopsy in Tumor cHaracterisation
NCT06816160 ·Status: RECRUITING
-
Collecting Solid Tumor Tissue to Identify New Treatments
NCT01658917 ·Status: COMPLETED
-
Studying Tumor Tissue Samples and Blood Samples to Learn More About DNA Changes in Patients With Lung Cancer
NCT00899405 ·Status: RECRUITING
-
Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma
NCT00004153 ·Status: COMPLETED ·Phase: NA
-
Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract
NCT00582647 ·Status: ACTIVE_NOT_RECRUITING
-
Consent for Obtaining Additional Tissue at the Time of a Diagnostic Biopsy
NCT01078350 ·Status: COMPLETED
-
Biopsies of Cancer Patients for Tumor Molecular Characterization
NCT01061944 ·Status: COMPLETED
-
Detection of Circulating Osteosarcoma Tumor Cells in the Blood of Patients Using the Polymerase Chain Reaction
NCT00588510 ·Status: COMPLETED
-
Tissue-of-origin Directing Therapy in Patients With Cancer of Unknown Primary
NCT03278600 ·Status: COMPLETED ·Phase: PHASE3
-
Collection of Tissue Blocks or Slides From Patients With Cancer
NCT02810405 ·Status: COMPLETED
-
Molecular Analysis of Thoracic Malignancies
NCT01385722 ·Status: ENROLLING_BY_INVITATION
-
A Comprehensive Study to Isolate Tumor-initiating Cells From Human Epithelial Malignancies
NCT01060319 ·Status: WITHDRAWN
-
Evaluation of Preexisting Immunity Markers in Human Tumor Tissue Sample
NCT00568867 ·Status: COMPLETED
-
Biopsy of Human Tumors for Cancer Stem Cell Characterization: a Feasibility Study
NCT00610415 ·Status: COMPLETED
-
Collection of Circulating Tumor Cells From the Peripheral Blood of Metastatic Breast Cancer Patients
NCT02904135 ·Status: COMPLETED
-
Pan-tumor MRD Study
NCT06605404 ·Status: RECRUITING
-
Tissue Collection for Studies of Lymph Cancer
NCT01676805 ·Status: RECRUITING
-
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
NCT02688517 ·Status: RECRUITING
-
Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing
NCT01556828 ·Status: TERMINATED
-
Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal
NCT05530759 ·Status: RECRUITING
-
Studying DNA in Tumor Tissue Samples From Patients With Localized or Metastatic Osteosarcoma
NCT01062438 ·Status: COMPLETED
-
Genetic Biomarkers in Tissue Samples From Patients With Osteosarcoma
NCT01807143 ·Status: COMPLETED
-
Collection of Blood, Bone Marrow, Tumor or Tissue Samples
NCT00043615 ·Status: COMPLETED
-
Utility of Plasma Circulating Tumor DNA (ctDNA) in Asymptomatic Subjects for the Detection of Neoplastic Disease
NCT02612350 ·Status: COMPLETED
-
Protein Expression in Human Neuroblastoma Tumor Samples
NCT01407731 ·Status: COMPLETED